skip to primary navigationskip to content

Therapies Workshop

We are all keen to know when and how new stem cell therapies will reach patients. At the SCI we believe it is important to involve patients in discussions about the best ways to achieve and regulate the delivery of advanced therapies.

 

In partnership with UK charity Genetic Alliance, we invited a group of representatives from patient charities and the biopharmaceutical sector to  discuss  the development of advanced stem cell therapies. Prof. Robin Franklin gave an overview of the potential of ongoing research as well as the challenges of bringing therapies to clinic.   

 

img 20151110 160108488

 

Visitors then met with Cora Olpe, Dan Howard, Simón Méndez-Ferrer & Thomas Moreau, who are conducting pioneering research in the field of haematology. They had a chance to look at a fascinating new way to make and mass produce platelets.

 

img 20151110 153647972

RSS Feed Latest news

Stem Cell Institute Group Leaders elected as EMBO members

Jul 07, 2020

Two Cambridge Stem Cell Institute Group Leaders are among the 63 scientists from around the world elected this year as Members and Associate Members of the European Molecular Biology Organisation (EMBO).

Institute PIs awarded university promotions

Jun 26, 2020

Many congratulations to our institute and affiliate PIs who have been awarded promotions through the University’s Academic Promotions process recognising their outstanding work.

Potentially cancerous cells kept in check by competitive neighbours, study of oesophagus finds

May 18, 2020

The expansion of ‘mutant’ cells that could lead to cancer is often kept in check by their neighbours, research from the Wellcome Sanger Institute, the University of Cambridge and their collaborators has found. The team discovered that when equally-matched cells in the oesophagus of mice coincided, they acted as a brake on one another’s growth.

Professor Ludovic Vallier elected to the Fellowship of the Academy of Medical Sciences

May 13, 2020

The Academy of Medical Sciences has elected 50 of the UK’s most prominent biomedical and health scientists to their Fellowship.

Key nose cells identified as likely COVID-19 virus entry points

Apr 23, 2020

Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to get into our cells.

View all news

The Cambridge Stem Cell Institute is a world-leading centre for stem cell research.

Our mission: to transform human health through a deep understanding of stem cell biology.

 

The Institute is funded by Wellcome and the Medical Research Council.

         

 

Sign up to our newsletter to stay up-to-date with news and events from the Cambridge stem cell community.